ALGT vs MRNA · rev $943.5M vs rev $145.0M
Allegiant Travel Company (ALGT) versus Moderna Inc (MRNA) — a side-by-side from cached financials, not a winner call.
Allegiant Travel Company (ALGT) is a airlines company listed on US.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stéphane Bancel M.B.A..
Latest reported ALGT revenue for 2026-06-30 was $943.5M. Net income was -$4.9M. Revenue was up 28.8% from 2026-03-31 to 2026-06-30. ALGT currently screens at market cap $1.02B.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
ALGT currently screens at market cap $1.02B. MRNA currently screens at market cap $24.52B.
Not investment advice. Open the ALGT and MRNA stock pages for the full models.
Not investment advice.